Related Experiment Video
Updated: Jun 27, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Connective tissue growth factor and cardiac fibrosis
A Daniels1, M van Bilsen, R Goldschmeding
1Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Insights
Connective tissue growth factor (CTGF) plays a key role in cardiac fibrosis, a condition leading to heart failure. Targeting CTGF may offer new treatments for heart disease.
Area of Science:
- Cardiovascular Biology
- Fibrosis Research
- Molecular Medicine
Background:
- Cardiac fibrosis, characterized by excessive extracellular matrix deposition, is a primary driver of cardiovascular diseases and heart failure.
- Connective tissue growth factor (CTGF) is increasingly recognized for its significant role in fibrotic processes across various tissues, including the heart.
- CTGF acts as a crucial orchestrator of local factors that promote cardiac fibrosis.
Purpose of the Study:
- To elucidate the role of CTGF in the pathogenesis of cardiac fibrosis.
- To investigate CTGF as a potential biomarker for cardiac fibrosis.
- To explore CTGF as a therapeutic target for mitigating cardiac fibrosis.
Main Methods:
- Review of accumulating evidence on CTGF function in cardiac fibrotic processes.
- Analysis of CTGF's role as a matricellular protein in cardiac remodeling.
- Evaluation of CTGF's potential in disease diagnosis and treatment.
Main Results:
- CTGF is central to the fibrotic process in the heart, orchestrating key fibrotic factors.
- The matricellular nature of CTGF positions it as a modulator of cardiac remodeling during fibrosis.
- Evidence supports CTGF's involvement in the development of cardiac dysfunction and heart failure.
Conclusions:
- CTGF is a pivotal factor in cardiac fibrosis development and progression.
- CTGF presents potential as a reliable biomarker for diagnosing cardiac fibrosis.
- Targeting CTGF offers a promising therapeutic strategy to combat cardiac fibrosis and prevent heart failure.
Abstract:
Cardiac fibrosis is a major pathogenic factor in a variety of cardiovascular diseases and refers to an excessive deposition of extracellular matrix components in the heart, which leads to cardiac dysfunction and eventually overt heart failure. Evidence is accumulating for a crucial role of connective tissue growth factor (CTGF) in fibrotic processes in several tissues including the heart. CTGF orchestrates the actions of important local factors evoking cardiac fibrosis. The central role of CTGF as a matricellular protein modulating the fibrotic process in cardiac remodelling makes it a possible biomarker for cardiac fibrosis and a potential candidate for therapeutic intervention to mitigate fibrosis in the heart.
Related Concept Videos
Introduction to Fibroblasts
Healing I: Introduction
TGF - β Signaling Pathway
Extracellular Matrix
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...

